Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 2;9(11):1075.
doi: 10.3390/antiox9111075.

A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases

Affiliations
Review

A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases

Shivkanya Fuloria et al. Antioxidants (Basel). .

Abstract

Continuous oxidation of carbohydrates, lipids, and amino acids generate extremely reactive carbonyl species (RCS). Human body comprises some important RCS namely hexanal, acrolein, 4-hydroxy-2-nonenal, methylglyoxal, malondialdehyde, isolevuglandins, and 4-oxo-2- nonenal etc. These RCS damage important cellular components including proteins, nucleic acids, and lipids, which manifests cytotoxicity, mutagenicity, multitude of adducts and crosslinks that are connected to ageing and various chronic diseases like inflammatory disease, atherosclerosis, cerebral ischemia, diabetes, cancer, neurodegenerative diseases and cardiovascular disease. The constant prevalence of RCS in living cells suggests their importance in signal transduction and gene expression. Extensive knowledge of RCS properties, metabolism and relation with metabolic diseases would assist in development of effective approach to prevent numerous chronic diseases. Treatment approaches for RCS associated diseases involve endogenous RCS metabolizers, carbonyl metabolizing enzyme inducers, and RCS scavengers. Limited bioavailability and bio efficacy of RCS sequesters suggest importance of nanoparticles and nanocarriers. Identification of RCS and screening of compounds ability to sequester RCS employ several bioassays and analytical techniques. Present review describes in-depth study of RCS sources, types, properties, identification techniques, therapeutic approaches, nanocarriers, and their role in various diseases. This study will give an idea for therapeutic development to combat the RCS associated chronic diseases.

Keywords: chronic diseases; identification; reactive carbonyl species; scavengers; treatment approach; validation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of commonly found RCS.
Figure 2
Figure 2
The RCS generation via polyol pathway (a); and glycolysis pathway (b).
Figure 3
Figure 3
Detrimental and beneficial effects of RCS (a); Cytotoxic effects of RCS leading to cellular or tissue dysfunction (b) [90,93,94].
Figure 3
Figure 3
Detrimental and beneficial effects of RCS (a); Cytotoxic effects of RCS leading to cellular or tissue dysfunction (b) [90,93,94].
Figure 4
Figure 4
Approaches to counteract RCS at different levels.
Figure 5
Figure 5
Methods for validation of lipoxidation targets.

Similar articles

Cited by

References

    1. Hwang S.W., Lee Y.-M., Aldini G., Yeum K.-J. Targeting reactive carbonyl species with natural sequestering agents. Molecules. 2016;21:280. doi: 10.3390/molecules21030280. - DOI - PMC - PubMed
    1. Davies S.S., Zhang L.S. Reactive carbonyl species scavengers—Novel therapeutic approaches for chronic diseases. Curr. Pharmacol. Rep. 2017;3:51–67. doi: 10.1007/s40495-017-0081-6. - DOI - PMC - PubMed
    1. Semchyshyn H.M. Reactive carbonyl species in vivo: Generation and dual biological effects. Sci. World J. 2014;2014:417842. doi: 10.1155/2014/417842. - DOI - PMC - PubMed
    1. Zimniak P. Relationship of electrophilic stress to aging. Free Radic. Biol. Med. 2011;51:1087–1105. doi: 10.1016/j.freeradbiomed.2011.05.039. - DOI - PMC - PubMed
    1. Voziyan P., Brown K.L., Chetyrkin S., Hudson B. Site-specific AGE modifications in the extracellular matrix: A role for glyoxal in protein damage in diabetes. Clin. Chem. Lab. Med. 2014;52:39–45. doi: 10.1515/cclm-2012-0818. - DOI - PMC - PubMed

LinkOut - more resources